The role of BAF (mSWI/SNF) complexes in mammalian neural development, Am. J. Med. Genet. C Semin. Med. Genet, vol.166, pp.333-349, 2014. ,
The Role of SWI/SNF Chromatin Remodeling Complexes in Hormone Crosstalk, Trends Plant Sci, vol.21, pp.594-608, 2016. ,
Truncating mutations of hSNF5/INI1 in aggressive paediatric cancer, Nature, vol.394, pp.203-206, 1998. ,
The spectrum of SWI/SNF mutations, ubiquitous in human cancers, PloS One, vol.8, p.55119, 2013. ,
Proteomic and bioinformatic analysis of mammalian SWI/SNF complexes identifies extensive roles in human malignancy, Nat. Genet, vol.45, pp.592-601, 2013. ,
ARID1A mutations in endometriosisassociated ovarian carcinomas, N. Engl. J. Med, vol.363, pp.1532-1543, 2010. ,
Five SWI genes are required for expression of the HO gene in yeast, J. Mol. Biol, vol.178, pp.853-868, 1984. ,
Genes affecting the regulation of SUC2 gene expression by glucose repression in Saccharomyces cerevisiae, Genetics, vol.108, pp.845-858, 1984. ,
Characterization of the yeast SWI1, SWI2, and SWI3 genes, which encode a global activator of transcription, Cell, vol.68, pp.573-583, 1992. ,
Mammalian SWI/SNF chromatin remodeling complexes and cancer: Mechanistic insights gained from human genomics, Sci. Adv, vol.1, p.1500447, 2015. ,
The SWI/SNF complex and cancer, Oncogene, vol.28, pp.1653-1668, 2009. ,
Cell cycle control of the yeast HO gene: cis-and trans-acting regulators, Cell, vol.48, pp.389-397, 1987. ,
Regulation of an intergenic transcript controls adjacent gene transcription in Saccharomyces cerevisiae, Genes Dev, vol.19, pp.2695-2704, 2005. ,
Reciprocal regulation of CD4/CD8 expression by SWI/SNF-like BAF complexes, Nature, vol.418, pp.195-199, 2002. ,
Purification and biochemical heterogeneity of the mammalian SWI-SNF complex, EMBO J, vol.15, pp.5370-5382, 1996. ,
The bromodomain: a chromatin-targeting module?, Nat. Struct. Biol, vol.6, pp.601-604, 1999. ,
Role of the LXCXE binding site in Rb function, Mol. Cell. Biol, vol.20, pp.6799-6805, 2000. ,
ATP-dependent chromatin remodelling: SWI/SNF and Co. are on the job, J. Mol. Biol, vol.293, pp.187-198, 1999. ,
A synthetic lethality-based strategy to treat cancers harboring a genetic deficiency in the chromatin remodeling factor BRG1, Cancer Res, vol.73, pp.5508-5518, 2013. ,
Functional epigenetics approach identifies BRM/SMARCA2 as a critical synthetic lethal target in BRG1-deficient cancers, Proc. Natl. Acad. Sci. U. S. A, vol.111, pp.3128-3133, 2014. ,
Vulnerabilities of mutant SWI/SNF complexes in cancer, Cancer Cell, vol.26, pp.309-317, 2014. ,
, SWI/SNF chromatin remodeling and human malignancies, vol.10, pp.145-171, 2015.
Linking long non-coding RNAs and SWI/SNF complexes to chromatin remodeling in cancer, Mol. Cancer, vol.16, p.42, 2017. ,
PBAF chromatin-remodeling complex requires a novel specificity subunit, BAF200, to regulate expression of selective interferon-responsive genes, Genes Dev, vol.19, pp.1662-1667, 2005. ,
, SnapShot: Chromatin remodeling: SWI/SNF, vol.144, 2011.
Understanding the words of chromatin regulation, Cell, vol.136, pp.200-206, 2009. ,
A Brg1 null mutation in the mouse reveals functional differences among mammalian SWI/SNF complexes, Mol. Cell, vol.6, pp.1287-1295, 2000. ,
Srg3, a mouse homolog of yeast SWI3, is essential for early embryogenesis and involved in brain development, Mol. Cell. Biol, vol.21, pp.7787-7795, 2001. ,
Brg1 is required for murine neural stem cell maintenance and gliogenesis, Dev. Biol, vol.289, pp.372-383, 2006. ,
URL : https://hal.archives-ouvertes.fr/hal-00188038
The murine SNF5/INI1 chromatin remodeling factor is essential for embryonic development and tumor suppression, EMBO Rep, vol.1, pp.500-506, 2000. ,
ES cell pluripotency and germ-layer formation require the SWI/SNF chromatin remodeling component BAF250a, Proc. Natl. Acad. Sci. U. S. A, vol.105, pp.6656-6661, 2008. ,
BAF250B-associated SWI/SNF chromatin-remodeling complex is required to maintain undifferentiated mouse embryonic stem cells, Stem Cells Dayt. Ohio, vol.26, pp.1155-1165, 2008. ,
SWI/SNF-Brg1 regulates self-renewal and occupies core pluripotency-related genes in embryonic stem cells, Stem Cells Dayt. Ohio, vol.27, pp.317-328, 2009. ,
An embryonic stem cell chromatin remodeling complex, esBAF, is an essential component of the core pluripotency transcriptional network, Proc. Natl. Acad. Sci. U. S. A, vol.106, pp.5187-5191, 2009. ,
An embryonic stem cell chromatin remodeling complex, esBAF, is essential for embryonic stem cell self-renewal and pluripotency, Proc. Natl. Acad. Sci. U. S. A, vol.106, pp.5181-5186, 2009. ,
An essential switch in subunit composition of a chromatin remodeling complex during neural development, Neuron, vol.55, pp.201-215, 2007. ,
Identification of a polymorphic, neuronspecific chromatin remodeling complex, Genes Dev, vol.16, pp.2509-2517, 2002. ,
Regulation of dendritic development by neuron-specific chromatin remodeling complexes, Neuron, vol.56, pp.94-108, 2007. ,
Components of the SWI/SNF complex are required for asymmetric cell division in C. elegans, Mol. Cell, vol.6, pp.617-624, 2000. ,
Nuclear reprogramming of human somatic cells by xenopus egg extract requires BRG1, Curr. Biol. CB, vol.14, pp.1475-1480, 2004. ,
The SWI/SNF chromatin remodeling protein Brg1 is required for vertebrate neurogenesis and mediates transactivation of Ngn and NeuroD, Dev. Camb. Engl, vol.132, pp.105-115, 2005. ,
Directed transdifferentiation of mouse mesoderm to heart tissue by defined factors, Nature, vol.459, pp.708-711, 2009. ,
Coordinate Nodal and BMP inhibition directs Baf60c-dependent cardiomyocyte commitment, Genes Dev, vol.27, pp.2332-2344, 2013. ,
Baf60c is essential for function of BAF chromatin remodelling complexes in heart development, Nature, vol.432, pp.107-112, 2004. ,
Epigenetic reprogramming of human embryonic stem cells into skeletal muscle cells and generation of contractile myospheres, Cell Rep, vol.3, pp.661-670, 2013. ,
SWI/SNF-directed stem cell lineage specification: dynamic composition regulates specific stages of skeletal myogenesis, Cell. Mol. Life Sci. CMLS, vol.73, pp.3887-3896, 2016. ,
The developmental and pathogenic roles of BAF57, a special subunit of the BAF chromatin-remodeling complex, FEBS Lett, vol.590, pp.1555-1569, 2016. ,
Role of BAF60a/BAF60c in chromatin remodeling and hepatic lipid metabolism, Nutr. Metab, vol.13, p.30, 2016. ,
esBAF facilitates pluripotency by conditioning the genome for LIF/STAT3 signalling and by regulating polycomb function, Nat. Cell Biol, vol.13, pp.903-913, 2011. ,
Epigenetic antagonism between polycomb and SWI/SNF complexes during oncogenic transformation, Cancer Cell, vol.18, pp.316-328, 2010. ,
The SWI/SNF chromatin remodelling complex is required for maintenance of lineage specific enhancers, Nat. Commun, vol.8, p.14648, 2017. ,
Dynamics of BAF-Polycomb complex opposition on heterochromatin in normal and oncogenic states, Nat. Genet, vol.49, pp.213-222, 2017. ,
, The role of INI1 and the SWI/SNF complex in the development of rhabdoid tumors: meeting summary from the workshop on childhood atypical teratoid/rhabdoid tumors, vol.62, pp.323-328, 2002.
, Rhabdoid tumors: integrating biological insights with clinical success: a report from the SMARCB1 and Rhabdoid Tumor Symposium, vol.207, pp.346-351, 2013.
Molecular pathways: SWI/SNF (BAF) complexes are frequently mutated in cancer--mechanisms and potential therapeutic insights, Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res, vol.20, pp.21-27, 2014. ,
Chromatin remodeling: from transcription to cancer, Cancer Genet, vol.207, pp.352-357, 2014. ,
Biology and Treatment of Rhabdoid Tumor, Crit. Rev. Oncog, vol.20, pp.199-216, 2015. ,
Mechanisms by which SMARCB1 loss drives rhabdoid tumor growth, Cancer Genet, vol.207, pp.365-372, 2014. ,
A remarkably simple genome underlies highly malignant pediatric rhabdoid cancers, J. Clin. Invest, vol.122, pp.2983-2988, 2012. ,
Cancer genome landscapes, Science, vol.339, pp.1546-1558, 2013. ,
Rhabdoid tumor of kidney. A report of 111 cases from the National Wilms' Tumor Study Pathology Center, Am. J. Surg. Pathol, vol.13, pp.439-458, 1989. ,
Central nervous system atypical teratoid/rhabdoid tumors of infancy and childhood: definition of an entity, J. Neurosurg, vol.85, pp.56-65, 1996. ,
Ultrastructure of malignant rhabdoid tumor of the kidney. A distinctive renal tumor of children, Hum. Pathol, vol.12, pp.646-657, 1981. ,
Malignant soft tissue neoplasms with the histologic features of renal rhabdoid tumors: an ultrastructural and immunohistochemical study, Hum. Pathol, vol.16, pp.1235-1242, 1985. ,
Small cell undifferentiated variant of hepatoblastoma: adverse clinical and molecular features similar to rhabdoid tumors, Pediatr. Blood Cancer, vol.52, pp.328-334, 2009. ,
SMARCB1 deficiency in tumors from the peripheral nervous system: a link between schwannomas and rhabdoid tumors?, Am. J. Surg. Pathol, vol.36, pp.964-972, 2012. ,
INI1-deficient tumors: diagnostic features and molecular genetics, Am. J. Surg. Pathol, vol.35, pp.47-63, 2011. ,
, SWI/SNF mediates polycomb eviction and epigenetic reprogramming of the INK4b-ARF-INK4a locus, vol.28, pp.3457-3464, 2008.
Epigenetic antagonism between polycomb and SWI/SNF complexes during oncogenic transformation, Cancer Cell, vol.18, pp.316-328, 2010. ,
SMARCB1 is required for widespread BAF complex-mediated activation of enhancers and bivalent promoters, Nat. Genet, vol.49, p.1613, 2017. ,
Extracranial rhabdoid tumours: what we have learned so far and future directions, Lancet Oncol, vol.14, issue.13, pp.70088-70091, 2013. ,
Germline nonsense mutation and somatic inactivation of SMARCA4/BRG1 in a family with rhabdoid tumor predisposition syndrome, Am. J. Hum. Genet, vol.86, pp.279-284, 2010. ,
Germline SMARCB1 mutation and somatic NF2 mutations in familial multiple meningiomas, J. Med. Genet, vol.48, pp.93-97, 2011. ,
URL : https://hal.archives-ouvertes.fr/hal-00573999
Schwannomatosis associated with multiple meningiomas due to a familial SMARCB1 mutation, Neurogenetics, vol.11, pp.73-80, 2010. ,
Schwannomatosis: a clinical and pathologic study, Neurology, vol.46, pp.1072-1079, 1996. ,
Germline mutation of INI1/SMARCB1 in familial schwannomatosis, Am. J. Hum. Genet, vol.80, pp.805-810, 2007. ,
Frequency of SMARCB1 mutations in familial and sporadic schwannomatosis, Neurogenetics, vol.13, pp.141-145, 2012. ,
Expression of SMARCB1 (INI1) mutations in familial schwannomatosis, Hum. Mol. Genet, vol.21, pp.5239-5245, 2012. ,
Epithelioid sarcoma is associated with a high percentage of SMARCB1 deletions, Mod. Pathol. Off. J. U. S. Can. Acad. Pathol. Inc, vol.26, pp.385-392, 2013. ,
Epithelioid sarcoma: a clinicopathologic and immunohistochemical analysis of 106 cases from the French sarcoma group, Am. J. Clin. Pathol, vol.131, pp.222-227, 2009. ,
Loss of INI1 expression is characteristic of both conventional and proximal-type epithelioid sarcoma, Am. J. Surg. Pathol, vol.33, pp.542-550, 2009. ,
SMARCB1/INI1 tumor suppressor gene is frequently inactivated in epithelioid sarcomas, Cancer Res, vol.65, pp.4012-4019, 2005. ,
INI1 and GLUT-1 expression in epithelioid sarcoma and its cutaneous neoplastic and nonneoplastic mimics, Am. J. Dermatopathol, vol.31, pp.152-156, 2009. ,
, A new cytogenetic finding in an epithelioid sarcoma, vol.72, pp.151-154, 1994.
Consistent SMARCB1 homozygous deletions in epithelioid sarcoma and in a subset of myoepithelial carcinomas can be reliably detected by FISH in archival material, Genes. Chromosomes Cancer, vol.53, pp.475-486, 2014. ,
Proximal-type" epithelioid sarcoma, a distinctive aggressive neoplasm showing rhabdoid features. Clinicopathologic, immunohistochemical, and ultrastructural study of a series, Am. J. Surg. Pathol, vol.21, pp.130-146, 1997. ,
Epitheloid sarcoma. A sarcoma simulating a granuloma or a carcinoma, Cancer, vol.26, pp.1029-1041, 1970. ,
, SMARCB1/INI1 inactivation in renal medullary carcinoma, pp.428-435, 2012.
Renal medullary carcinoma: rhabdoid features and the absence of INI1 expression as markers of aggressive behavior, Mod. Pathol. Off. J. U. S. Can. Acad. Pathol. Inc, vol.21, pp.647-652, 2008. ,
Balanced Translocations Disrupting SMARCB1 Are Hallmark Recurrent Genetic Alterations in Renal Medullary Carcinomas, Eur. Urol, vol.69, pp.1055-1061, 2016. ,
Renal medullary carcinoma: the Bronx experience, Urology, vol.70, pp.878-882, 2007. ,
Uncommon and recently described renal carcinomas, Mod. Pathol. Off. J. U. S. Can. Acad. Pathol. Inc, vol.22, issue.2, 2009. ,
Renal medullary carcinoma. The seventh sickle cell nephropathy, Am. J. Surg. Pathol, vol.19, pp.1-11, 1995. ,
Renal medullary carcinoma: clinical, pathologic, immunohistochemical, and genetic analysis with pathogenetic implications, Urology, vol.60, pp.1083-1089, 2002. ,
The expanding family of SMARCB1(INI1)-deficient neoplasia: implications of phenotypic, biological, and molecular heterogeneity, Adv. Anat. Pathol, vol.21, pp.394-410, 2014. ,
SMARCB1 (INI-1)-deficient carcinomas of the sinonasal tract, Am. J. Surg. Pathol, vol.38, pp.1282-1289, 2014. ,
SMARCB1 (INI-1)-deficient Sinonasal Carcinoma: A Series of 39 Cases Expanding the Morphologic and Clinicopathologic Spectrum of a Recently Described Entity, Am. J. Surg. Pathol, vol.41, pp.458-471, 2017. ,
Sinonasal carcinoma: clinical, pathological, genetic and therapeutic advances, Nat. Rev. Clin. Oncol, vol.11, pp.460-472, 2014. ,
SMARCB1/INI1-deficient sinonasal carcinoma shows methylation of RASSF1 gene: A clinicopathological, immunohistochemical and molecular genetic study of a recently described entity, Pathol. Res. Pract, vol.213, pp.133-142, 2017. ,
Diagnostic value of next-generation sequencing in an unusual sphenoid tumor, The Oncologist, vol.19, pp.623-630, 2014. ,
Poorly differentiated chordoma with SMARCB1/INI1 loss: a distinct molecular entity with dismal prognosis, Acta Neuropathol. (Berl.), vol.132, pp.149-151, 2016. ,
Reversible disruption of mSWI/SNF (BAF) complexes by the SS18-SSX oncogenic fusion in synovial sarcoma, Cell, vol.153, pp.71-85, 2013. ,
2) translocation found in human synovial sarcoma, Nat. Genet, vol.7, pp.502-508, 1994. ,
Abstract 3875: SSX drives gain-of-function BAF complex chromatin affinity and genomic targeting in synovial sarcoma, Cancer Res, vol.77, pp.3875-3875, 2017. ,
Prognostic value of SS18-SSX fusion type in synovial sarcoma; systematic review and meta-analysis, SpringerPlus, p.375, 2015. ,
Characterization of mammary tumors from Brg1 heterozygous mice, Oncogene, vol.27, pp.460-468, 2008. ,
Germline and somatic SMARCA4 mutations characterize small cell carcinoma of the ovary, hypercalcemic type, Nat. Genet, vol.46, pp.438-443, 2014. ,
, SMARCA4 inactivation defines a group of undifferentiated thoracic malignancies transcriptionally related to BAFdeficient sarcomas, vol.47, pp.1200-1205, 2015.
URL : https://hal.archives-ouvertes.fr/hal-01684775
Small cell carcinoma of the ovary, hypercalcemic type. A clinicopathological analysis of 150 cases, Am. J. Surg. Pathol, vol.18, pp.1102-1116, 1994. ,
Loss of the tumor suppressor SMARCA4 in small cell carcinoma of the ovary, hypercalcemic type (SCCOHT), Rare Dis, Austin Tex, vol.2, p.967148, 2014. ,
Recurrent SMARCA4 mutations in small cell carcinoma of the ovary, Nat. Genet, vol.46, pp.424-426, 2014. ,
No small surprise -small cell carcinoma of the ovary, hypercalcaemic type, is a malignant rhabdoid tumour, J. Pathol, vol.233, pp.209-214, 2014. ,
,
Clinicopathological and molecular characterization of SMARCA4-deficient thoracic sarcomas with comparison to potentially related entities, Mod. Pathol. Off. J. U. S. Can. Acad. Pathol. Inc, 2017. ,
The genetic landscape of mutations in Burkitt lymphoma, Nat. Genet, vol.44, pp.1321-1325, 2012. ,
Genetic and epigenetic screening for gene alterations of the chromatin-remodeling factor, SMARCA4/BRG1, in lung tumors, Genes. Chromosomes Cancer, vol.41, pp.170-177, 2004. ,
, Frequent BRG1/SMARCA4-inactivating mutations in human lung cancer cell lines, vol.29, pp.617-622, 2008.
Mapping the hallmarks of lung adenocarcinoma with massively parallel sequencing, Cell, vol.150, pp.1107-1120, 2012. ,
Exome and whole-genome sequencing of esophageal adenocarcinoma identifies recurrent driver events and mutational complexity, Nat. Genet, vol.45, pp.478-486, 2013. ,
The mutational landscape of adenoid cystic carcinoma, Nat. Genet, vol.45, pp.791-798, 2013. ,
Recurrent Fusions in MYB and MYBL1 Define a Common, Transcription Factor-Driven Oncogenic Pathway in Salivary Gland Adenoid Cystic Carcinoma, Cancer Discov, vol.6, pp.176-187, 2016. ,
SWI/SNF Complexdeficient Undifferentiated/Rhabdoid Carcinomas of the Gastrointestinal Tract: A Series of 13 Cases Highlighting Mutually Exclusive Loss of SMARCA4 and SMARCA2 and Frequent Coinactivation of SMARCB1 and SMARCA2, Am. J. Surg. Pathol, vol.40, pp.544-553, 2016. ,
, Residual Complexes Containing SMARCA2 (BRM) Underlie the Oncogenic Drive of SMARCA4 (BRG1) Mutation, vol.34, pp.1136-1144, 2014.
Dual loss of the SWI/SNF complex ATPases SMARCA4/BRG1 and SMARCA2/BRM is highly sensitive and specific for small cell carcinoma of the ovary, hypercalcaemic type, J. Pathol, vol.238, pp.389-400, 2016. ,
Functional epigenetics approach identifies BRM/SMARCA2 as a critical synthetic lethal target in BRG1-deficient cancers, Proc. Natl. Acad. Sci. U. S. A, vol.111, pp.3128-3133, 2014. ,
A synthetic lethality-based strategy to treat cancers harboring a genetic deficiency in the chromatin remodeling factor BRG1, Cancer Res, vol.73, pp.5508-5518, 2013. ,
Concomitant loss of SMARCA2 and SMARCA4 expression in small cell carcinoma of the ovary, hypercalcemic type, Mod. Pathol, vol.29, pp.60-66, 2016. ,
Molecular analyses reveal close similarities between small cell carcinoma of the ovary, hypercalcemic type and atypical teratoid/rhabdoid tumor, Oncotarget, vol.7, pp.1732-1740, 2016. ,
SMARCA4-deficient thoracic sarcoma: a distinctive clinicopathological entity with undifferentiated rhabdoid morphology and aggressive behavior, Mod. Pathol, 2017. ,
SMARCB1-mediated SWI/SNF complex function is essential for enhancer regulation, Nat. Genet, vol.49, pp.289-295, 2017. ,
Selective Killing of SMARCA2-and SMARCA4-deficient Small Cell Carcinoma of the Ovary, Hypercalcemic Type Cells by Inhibition of EZH2: In Vitro and In Vivo Preclinical Models, Mol. Cancer Ther, vol.16, pp.850-860, 2017. ,
Loss-of-function mutations in SMARCE1 cause an inherited disorder of multiple spinal meningiomas, Nat. Genet, vol.45, pp.295-298, 2013. ,
Germline SMARCE1 mutations predispose to both spinal and cranial clear cell meningiomas, J. Pathol, vol.234, pp.436-440, 2014. ,
Olderode-Berends, A heritable form of SMARCE1-related meningiomas with important implications for follow-up and family screening, Neurogenetics, vol.17, pp.83-89, 2016. ,
Integrated analysis of somatic mutations and focal copynumber changes identifies key genes and pathways in hepatocellular carcinoma, Nat. Genet, vol.44, pp.694-698, 2012. ,
URL : https://hal.archives-ouvertes.fr/inserm-00719917
Exome sequencing of hepatitis B virus-associated hepatocellular carcinoma, Nat. Genet, vol.44, pp.1117-1121, 2012. ,
Whole-genome sequencing and comprehensive molecular profiling identify new driver mutations in gastric cancer, Nat. Genet, vol.46, pp.573-582, 2014. ,
Exome sequencing of gastric adenocarcinoma identifies recurrent somatic mutations in cell adhesion and chromatin remodeling genes, Nat. Genet, vol.44, pp.570-574, 2012. ,
Exome sequencing identifies frequent mutation of ARID1A in molecular subtypes of gastric cancer, Nat. Genet, vol.43, pp.1219-1223, 2011. ,
Frequent mutations of chromatin remodeling genes in transitional cell carcinoma of the bladder, Nat. Genet, vol.43, pp.875-878, 2011. ,
Whole-genome and whole-exome sequencing of bladder cancer identifies frequent alterations in genes involved in sister chromatid cohesion and segregation, Nat. Genet, vol.45, pp.1459-1463, 2013. ,
Exome sequencing identifies frequent inactivating mutations in BAP1, ARID1A and PBRM1 in intrahepatic cholangiocarcinomas, Nat. Genet, vol.45, pp.1470-1473, 2013. ,
Frequent mutations of chromatin remodeling gene ARID1A in ovarian clear cell carcinoma, Science, vol.330, pp.228-231, 2010. ,
Clear cell carcinoma of the ovary: a distinct histologic type with poor prognosis and resistance to platinum-based chemotherapy in stage III disease, Gynecol. Oncol, vol.60, pp.412-417, 1996. ,
Clinical characteristics of clear cell carcinoma of the ovary: a distinct histologic type with poor prognosis and resistance to platinum-based chemotherapy, Cancer, vol.88, pp.2584-2589, 2000. ,
Lack of effective systemic therapy for recurrent clear cell carcinoma of the ovary, Gynecol. Oncol, vol.105, pp.404-408, 2007. ,
Exome sequencing of serous endometrial tumors identifies recurrent somatic mutations in chromatin-remodeling and ubiquitin ligase complex genes, NIH Intramural Sequencing Center (NISC) Comparative Sequencing Program, vol.44, pp.1310-1315, 2012. ,
Integrated genomic analyses identify ARID1A and ARID1B alterations in the childhood cancer neuroblastoma, Nat. Genet, vol.45, pp.12-17, 2013. ,
Frameshift mutations of a chromatin-remodeling gene SMARCC2 in gastric and colorectal cancers with microsatellite instability, APMIS Acta Pathol. Microbiol. Immunol. Scand, vol.121, pp.168-169, 2013. ,
Linking the SWI/SNF complex to prostate cancer, Nat. Genet, vol.45, pp.1268-1269, 2013. ,
The long noncoding RNA SChLAP1 promotes aggressive prostate cancer and antagonizes the SWI/SNF complex, Nat. Genet, vol.45, pp.1392-1398, 2013. ,
The long noncoding RNA lncTCF7 promotes self-renewal of human liver cancer stem cells through activation of Wnt signaling, Cell Stem Cell, vol.16, pp.413-425, 2015. ,
Diverse Roles and Interactions of the SWI/SNF Chromatin Remodeling Complex Revealed Using Global Approaches, PLOS Genet, vol.7, p.1002008, 2011. ,
, Aberrant BAF57 signaling facilitates prometastatic phenotypes, vol.19, pp.2657-2667, 2013.
Prognostic significance of BAF57 expression in patients with endometrial carcinoma, Histol. Histopathol, vol.27, pp.593-599, 2012. ,
The histone methyltransferase EZH2 is a therapeutic target in small cell carcinoma of the ovary, hypercalcemic type, J. Pathol, 2017. ,
EZH2 inhibition sensitizes BRG1 and EGFR mutant lung tumours to TopoII inhibitors, Nature, vol.520, pp.239-242, 2015. ,
BAF complexes facilitate decatenation of DNA by topoisomerase II?, Nature, vol.497, pp.624-627, 2013. ,
P16INK4a is required for hSNF5 chromatin remodelerinduced cellular senescence in malignant rhabdoid tumor cells, J. Biol. Chem, vol.279, pp.3807-3816, 2004. ,
Cancer-associated mutations in chromatin remodeler hSNF5 promote chromosomal instability by compromising the mitotic checkpoint, Genes Dev, vol.19, pp.665-670, 2005. ,
A Phase I Study of the CDK4/6 Inhibitor Ribociclib (LEE011) in Pediatric Patients with Malignant Rhabdoid Tumors, Neuroblastoma, and Other Solid Tumors, Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res, vol.23, pp.2433-2441, 2017. ,
Residual complexes containing SMARCA2 (BRM) underlie the oncogenic drive of SMARCA4 (BRG1) mutation, Mol. Cell. Biol, vol.34, pp.1136-1144, 2014. ,
Loss of BRG1/BRM in human lung cancer cell lines and primary lung cancers: correlation with poor prognosis, Cancer Res, vol.63, pp.560-566, 2003. ,
SMARCA4-deficient pulmonary adenocarcinoma: clinicopathological, immunohistochemical, and molecular characteristics of a novel aggressive neoplasm with a consistent TTF1(neg)/CK7(pos)/HepPar-1(pos) immunophenotype, Virchows Arch, 2017. ,
The SWI/SNF chromatin-remodeling complex and glucocorticoid resistance in acute lymphoblastic leukemia, J. Natl. Cancer Inst, vol.100, pp.1792-1803, 2008. ,
Expression of BAF57 in ovarian cancer cells and drug sensitivity, Cancer Sci, vol.106, pp.359-366, 2015. ,
SMARCE1 suppresses EGFR expression and controls responses to MET and ALK inhibitors in lung cancer, Cell Res, vol.25, pp.445-458, 2015. ,
Haploinsufficiency of Snf5 (integrase interactor 1) predisposes to malignant rhabdoid tumors in mice, Proc. Natl. Acad. Sci. U. S. A, vol.97, pp.13796-13800, 2000. ,
Renal medullary carcinoma: molecular, immunohistochemistry, and morphologic correlation, Am. J. Surg. Pathol, vol.37, pp.368-374, 2013. ,
Rhabdoid Tumor Predisposition Syndrome, Pediatr. Dev. Pathol, vol.18, pp.49-58, 2015. ,
Loss of SMARCB1/INI1 expression in poorly differentiated chordomas, Acta Neuropathol. (Berl.), vol.120, pp.745-753, 2010. ,
SMARCB1(INI1)-deficient sinonasal basaloid carcinoma: a novel member of the expanding family of SMARCB1-deficient neoplasms, Am. J. Surg. Pathol, vol.38, pp.1274-1281, 2014. ,
Small cell carcinoma of the ovary, hypercalcemic type, displays frequent inactivating germline and somatic mutations in SMARCA4, Nat. Genet, vol.46, pp.427-429, 2014. ,
Familial rhabdoid tumour 'avant la lettre'--from pathology review to exome sequencing and back again, J. Pathol, vol.231, pp.35-43, 2013. ,
Whole-exome sequencing combined with functional genomics reveals novel candidate driver cancer genes in endometrial cancer, Genome Res, vol.22, pp.2120-2129, 2012. ,
Somatic mutations in the chromatin remodeling gene ARID1A occur in several tumor types, Hum. Mutat, vol.33, pp.100-103, 2012. ,
An integrated genomic approach identifies ARID1A as a candidate tumor-suppressor gene in breast cancer, Oncogene, vol.31, pp.2090-2100, 2012. ,
Mutations and deletions of ARID1A in breast tumors, Oncogene, vol.31, pp.4255-4256, 2012. ,
Recurrent inactivating mutations of ARID2 in non-small cell lung carcinoma, Int. J. Cancer, vol.132, pp.2217-2221, 2013. ,
BAF180 is a critical regulator of p21 induction and a tumor suppressor mutated in breast cancer, Cancer Res, vol.68, pp.1667-1674, 2008. ,
Exome sequencing identifies frequent mutation of the SWI/SNF complex gene PBRM1 in renal carcinoma, Nature, vol.469, pp.539-542, 2011. ,
The TLX1 oncogene drives aneuploidy in T cell transformation, Nat. Med, vol.16, pp.1321-1327, 2010. ,
Groupe Français de Cytogénétique Hématologique (GFCH), t(5;14)/HOX11L2-positive T-cell acute lymphoblastic leukemia. A collaborative study of the Groupe Français de Cytogénétique Hématologique (GFCH), Leukemia, vol.17, pp.1851-1857, 2003. ,